We carry out a number of different types of studies, including basic science work (research performed within a laboratory) and clinical trials (involving patients, assessing the effect of a change such as a new drug or lifestyle intervention).
Your consultant will be able to inform you if you are eligible for any of the trials or studies that the unit is currently involved in.
We are actively recruiting to:
A UK-wide project aimed at improving understanding of autoimmune hepatitis and the way it impacts on the lives of patients.
The aim of this study is to develop, robustly validate and advance towards regulatory qualification biomarkers that diagnose, risk stratify and/or monitor NAFLD/NASH progression and fibrosis stage.
An interview/questionnaire for patients with compensated cirrhosis due to NASH.
Phase 3 study for the efficacy and safety of cenicriviroc for the treatment of liver fibrosis in adults with NASH.
Aims to create an international biobank resource to enable research into the causes and characteristics of drug-induced liver injury so that new, non-invasive diagnostic tests can be developed.